Last reviewed · How we verify
NOAVIA Honey beef fat cream (CERA)
At a glance
| Generic name | CERA |
|---|---|
| Also known as | Full name: Continuous Erythropoietic Receptor Activator, Abbreviation : CERA, Generic name: Methoxy polyethylene glycol-epoetin beta, Brand name：Mircera® |
| Sponsor | Beijing JUNGE Technology Co., Ltd. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cera™ Vascular Plug System Post-Market Clinical Follow-Up
- Vafseo Outcomes In-Center Experience (PHASE3)
- CETIC-I (CEra Traction Improves Cervical Kyphosis -I) (NA)
- CEFID-I (CEra Flow Improves DVT-1) (NA)
- CEFID-II (CEra Flow Improves DVT-II) (NA)
- CETIS-I (CEra Traction Improves Spine-I) (NA)
- A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA. (PHASE3)
- A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |